KRASG12C IN-2
KRASG12C IN-2 (compound 17) is an orally bioavailable small molecule inhibitor targeting the KRAS G12C mutant. It demonstrates potent activity in biochemical and cellular assays and has shown efficacy in suppressing tumor growth in mouse xenograft models, supporting its use in oncology research.
Product Specifications
Field of Research
Pharmacology & Drug Discovery, Signal Transduction
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog